Evidence map›Paper›PMID 32054728›Full record

Observational studyTobacco control2021

Impact of e-cigarette use among a cohort of American Indian cigarette smokers: associations with cigarette smoking cessation and cigarette consumption.

Ashley L Comiford, Dorothy A Rhoades, Paul Spicer, Justin D Dvorak, Kai Ding, Theodore L Wagener, Mark P Doescher

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Tobacco control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ashley L ComifordCommunity Health Promotions, Cherokee Nation, Tahlequah, Oklahoma, USA ashley-comiford@cherokee.org.ORCID 0000-0001-6951-4737
Dorothy A RhoadesStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-4031-3576
Paul SpicerAnthropology, University of Oklahoma, Norman, Oklahoma, USA.
Justin D DvorakDepartment of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Kai DingDepartment of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Theodore L WagenerDepartment of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0000-0002-9072-228X
Mark P DoescherStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
University of Oklahoma Health Sciences Center · USCherokee Nation · USThe Ohio State University Wexner Medical Center · USUniversity of Oklahoma · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Janis E Campbell · 2013 to 2026
$68.2M
Vaping among Smokers: a Cherokee Nation Cohort StudyP20CA202921 · NCI · UNIVERSITY OF OKLAHOMA · PI JERVIS, LORI L · 2015 to 2018
$1.2M
Vaping among Smokers, a Cherokee Nation Cohort StudyP20CA202923 · NCI · CHEROKEE NATION · PI KHAN, SOHAIL IMRAN · 2015 to 2018
$363k
NCI NIH HHS P20 CA202921NCI NIH HHS P20 CA202923NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

introductionDespite American Indian/Alaska Native (AI/AN) people having the highest prevalence of cigarette smoking nationwide, few studies have evaluated e-cigarette use among AI/AN adults who smoke. The primary objective of this observational pilot cohort study was to determine if e-cigarette use is associated with cigarette smoking cessation or reduction among adult AI individuals who smoke.

methodsIn 2016, we collected baseline survey and biomarker data among AI adults who smoke. The survey included questions about cigarette consumption and use of e-cigarettes and biomarkers, such as salivary cotinine markers and exhaled carbon monoxide. After 18 months, we repeated data collection, and asked about changes in cigarette smoking status and cigarettes per day (CPD). Comparisons between groups were performed using the χ

resultsOf 375 baseline participants, 214 (57.07%) returned for follow-up and were included in analyses. Of these, 20 (9.3%) reported having stopped cigarette smoking and had biochemical verification of cigarette smoking abstinence. Among those who quit smoking, 15% were baseline e-cigarette users; while among those who continued to smoke at follow-up, about 11% were baseline e-cigarette users. This difference was not statistically significant (p=0.48). Among all those who continued to smoke at follow-up, there was no overall decrease in CPD, nor a significant difference in change in CPD between baseline e-cigarette users and non-users (p=0.98).

conclusionsE-cigarette use at baseline was not associated with smoking cessation or a change in CPD in this cohort of AI adults who smoke after an 18-month follow-up period.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco ProductsVapingAdultAmerican Indian or Alaska NativeCohort StudiesHumansPilot ProjectsSmokerscessationdisparitieselectronic nicotine delivery devices

Identifiers

PMID32054728
PMCPMC8132298
OpenAlexW3006194175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.